Close menu




December 23rd, 2020 | 09:15 CET

Alibaba, Upco International, Palantir - the next boom!

  • Technology
Photo credits: pixabay.com

Topics such as data mining, artificial intelligence or blockchain technology, not only as the technical basis for cryptocurrencies such as Bitcoin or Etherum, are on everyone's lips and will continue to accompany us in everyday life as well as on the stock exchange in the coming years. The potential for these novel technologies is enormous. More and more young companies with innovative business models are entering the capital market. However, the digital transformation is also an opportunity for established companies to reposition themselves, thereby achieving a significantly higher valuation in the future.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: CA9152971052 , US69608A1088 , US01609W1027

Table of contents:


    Business model at the end

    The business model of telecom service provider Upco International was dead as a doornail until May 2020, when the entire management team was replaced and Andrea Pagani, a CEO with a career spanning more than 20 years in the telecommunications industry, was appointed. The first goal was to split the general store into two independent business units. The first is the Wholesale Telecom unit which corresponds to the classic telecommunications wholesale business. Here, better contract terms with international telecommunications providers are achieved by pooling many smaller customers for cross-border telephone traffic.

    Wholesale Telecom is coordinated by Upco International but operationally managed by dedicated companies. These companies will be integrated into the Upco group of companies over time. About four weeks ago, the first acquisition was successful. Equinox is a niche operator based in the Dominican Republic that provides telecommunications services to immigrants from Central and South America and the Caribbean to the United States.

    Everything from a single source

    Although the two segments are separate, customers are free to use any of the Upco Group's services. This option increases the customer base to monetize digital services with the second segment. Here, the Canadians are positioning themselves to respond efficiently to digital transformation by focusing on two key areas: Voice and Data Services and Digital Payments and Money Transfers. Voice and data services such as voice over IP and chats will be handled by UpcoNet, while UpcoPay will handle digital payments.

    From telecom provider to blockchain

    Initially, UpcoPay will run as an innovative, highly secure, based on a blockchain, direct payment method between individuals or people and merchants. Building on this, after implementing an e-wallet, it will be possible to top up money, process payments, or even transfer foreign exchange without setting up an account or entering sensitive banking information.

    From 2021, Upco users in Europe will then be able to use UpcoPay to send and receive money quickly, securely, and without using a credit or debit card, but much more cheaply than competitors such as Western Union or PayPal. This service will be expanded over time to other areas such as retail and hospitality. Upco International has a unique starting position from the mix of telecom provider and international digital payment services.

    Mamma mia...

    That's what investors thought when Chinese authorities put the kibosh on the planned IPO of Alibaba subsidiary Ant Group two days before the launch date. Initially, the IPO was expected to raise more than USD 35 billion, making it the largest ever. Now insiders assume that the IPO will not be achieved until 2022. The regulatory changes demanded by the authorities are too great. Yesterday, the Wall Street Journal reported that Jack Ma, CEO of Alibaba Group, even tried to change the Chinese government's mind with a block of shares in Ant Group, which, however, they declined with thanks.

    Shares before comeback

    Much negativity is already priced into the chart of the tech giant. Thus, after the horror news announcement, the value plummeted from its all-time high of USD 319.32 to currently, USD 256.00. In recent weeks, the stock has been able to establish a broad stabilization zone around USD 252.00. Should Alibaba, whose long-term uptrend remains intact, reach the first resistance at USD 260.00, price gains up to USD 304.00 will soon be possible. In the long term, we remain positive on the stock.

    The data octopus is growing

    It is undoubtedly one of the most controversial Companies on the capital market. Nevertheless, customers are flying to the data analytics Company Palantir in droves. In addition to cooperating with intelligence agencies such as the CIA and the NSA and the US military, last week the US Company announced the signing of a three-year contract worth millions with the US Food and Drug Administration. The day before, closer cooperation with Greece was agreed upon. As a result, the Company said revenues are expected to pick up to about USD 1.07 billion this year, a 44% year-on-year growth. For 2021, the data-mining Company is targeting 2020 revenue growth of more than 30%.

    Big Brother about to break out

    Chart-wise, Palantir is on the verge of a breakout. In recent weeks, the chart formed a triangle formation. A breakout above USD 28.54 would quickly lead towards the all-time high at USD 33.50. Looking at the indicators, the overbought condition could be reduced in recent weeks. Based on this, the share should have enough strength after a successful breakout to reach the next price target of USD 42.00.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read